Nontuberculous Mycobacteria Clinical Trials

1 recruiting

Nontuberculous Mycobacteria Trials at a Glance

9 actively recruiting trials for nontuberculous mycobacteria are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 4 with 2 trials, with the heaviest enrollment activity in New York, Toronto, and Nijmegen. Lead sponsors running nontuberculous mycobacteria studies include NYU Langone Health, Oregon Health and Science University, and National Jewish Health.

Browse nontuberculous mycobacteria trials by phase

Treatments under study

About Nontuberculous Mycobacteria Clinical Trials

Looking for clinical trials for Nontuberculous Mycobacteria? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Nontuberculous Mycobacteria trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Nontuberculous Mycobacteria clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Exercise Program in Patients With Nontuberculous Mycobacterial Pulmonary Disease

Nontuberculous Mycobacterial Pulmonary Disease
Yonsei University50 enrolled1 locationNCT06488495
Recruiting

Evaluation Of The Lung Microbiome In NTM Bronchiectasis

BronchiectasisNontuberculous Mycobacteria
NYU Langone Health1,000 enrolled1 locationNCT02779478
Recruiting

Biomarkers of Phage Treatment Response in NTM and Other Infections

Nontuberculous Mycobacterial Lung Disease
NYU Langone Health100 enrolled1 locationNCT07076238
Recruiting
Phase 4

Hypertonic Saline for MAC

Nontuberculous Mycobacterium InfectionNontuberculous Mycobacterial Lung Disease
Oregon Health and Science University50 enrolled3 locationsNCT04921943
Recruiting
Phase 4

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease

Nontuberculous Mycobacterial Lung DiseaseMycobacterium Avium Complex
Radboud University Medical Center30 enrolled1 locationNCT05192057
Recruiting

Rehabilitation Exercise and Education of Airway Clearance Technique in NTM-PD: A Prospective Cohort Study

Nontuberculous Mycobacterial Pulmonary Disease
Seoul National University Bundang Hospital500 enrolled1 locationNCT06838442
Recruiting

M. Avium WGS During Mav-PD Treatment

Respiratory Tract DiseasesMycobacterium AviumMycobacterium Infections, Nontuberculous+2 more
University Health Network, Toronto40 enrolled1 locationNCT06266442
Recruiting

Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)

Nontuberculous Mycobacterial Pulmonary InfectionOutbreak Investigation
National Jewish Health100 enrolled1 locationNCT06155747
Recruiting

Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical Determinants of Relapse and Outcome

Nontuberculous Mycobacterial Lung Disease
University of Virginia720 enrolled1 locationNCT05277857